Role of C3a Receptors, C5a Receptors, and Complement Protein C6 Deficiency in Collagen Antibody-Induced Arthritis in Mice-Reference-Cited by-同舟云学术

Role of C3a Receptors, C5a Receptors, and Complement Protein C6 Deficiency in Collagen Antibody-Induced Arthritis in Mice

Published:2011-12-28 Issue:3 Volume:188 Page:1469-1478
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Banda Nirmal K.,Hyatt Stephanie,Antonioli Alexandra H.,White Jason T.,Glogowska Magdalena,Takahashi Kazue,Merkel Tod J.,Stahl Gregory L.,Mueller-Ortiz Stacey,Wetsel Rick,Arend William P.,Holers V. Michael

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference49 articles.

1. Rheumatoid Arthritis

2. Evolving concepts of rheumatoid arthritis

3. Pathogenic Complement Activation in Collagen Antibody- Induced Arthritis in Mice Requires Amplification by the Alternative Pathway

4. Essential Role of Complement Mannose-Binding Lectin-Associated Serine Proteases-1/3 in the Murine Collagen Antibody-Induced Model of Inflammatory Arthritis

5. Alternative Complement Pathway Activation Is Essential for Inflammation and Joint Destruction in the Passive Transfer Model of Collagen-Induced Arthritis

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Intervertebral Disc Degeneration Induced by Endplate Drilling or Needle Puncture in Complement C6-Sufficient and C6-Deficient Rabbits;Biomedicines;2024-07-30

2. Anaphylatoxins and their corresponding receptors as potential drivers in cartilage calcification during osteoarthritis progression;Osteoarthritis and Cartilage;2024-05

3. Expression and function of VISTA on myeloid cells;Biochemical Pharmacology;2024-04

4. Fcgr2b and Fcgr3 are the major genetic factors for cartilage antibody‐induced arthritis, overriding the effect of Hc encoding complement C5;European Journal of Immunology;2024-02-05

5. The role of the complement system in cancer etiology and management;Clinical Immuno-Oncology;2024